Search research articles
Contact Us
Filters
Showing results (11-20 of 18) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Infection
|
February 2, 2025
Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study
Jennifer K Quint, Sabada Dube, Lucy Carty, et al.
The Lancet Regional Health. Europe
|
August 19, 2024
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747]
Rachael A Evans, Sabada Dube, Yi Lu, et al.
The Lancet Regional Health. Europe
|
December 20, 2023
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study
Rachael A Evans, Sabada Dube, Yi Lu, et al.
European Journal of Public Health
|
January 21, 2025
Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case-control study
Leonie de Munter, Wilhelmine Meeraus, Akshat Dwivedi, et al.
The Journal of Infection
|
March 2, 2023
Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana
Emily Shava, Alane Izu, Tendani Gaolathe, et al.
IJID Regions
|
December 13, 2023
Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study results
Joseph Makhema, Emily Shava, Alane Izu, et al.
The Journal of Cell Biology
|
July 8, 2015
Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves
Jose A Gomez-Sanchez, Lucy Carty, Marta Iruarrizaga-Lejarreta, et al.
The Journal of Infection
|
March 2, 2024
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Wilhelmine Meeraus, Mark Joy, Mario Ouwens, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 18) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 18 results.
The Journal of Infection
|
February 2, 2025
Immunocompromised individuals remain at risk of COVID-19: 2023 results from the observational INFORM study
Jennifer K Quint, Sabada Dube, Lucy Carty, et al.
The Lancet Regional Health. Europe
|
August 19, 2024
Corrigendum to 'Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study' [The Lancet Regional Health - Europe 35 (2023) 100747]
Rachael A Evans, Sabada Dube, Yi Lu, et al.
The Lancet Regional Health. Europe
|
December 20, 2023
Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study
Rachael A Evans, Sabada Dube, Yi Lu, et al.
European Journal of Public Health
|
January 21, 2025
Effectiveness of the AZD1222 vaccine against COVID-19 hospitalization in Europe: final results from the COVIDRIVE test-negative case-control study
Leonie de Munter, Wilhelmine Meeraus, Akshat Dwivedi, et al.
The Journal of Infection
|
March 2, 2023
Safety and incidence of COVID-19 following ChAdOx1(AZD1222) COVID-19 vaccination in Botswana
Emily Shava, Alane Izu, Tendani Gaolathe, et al.
IJID Regions
|
December 13, 2023
Safety of AZD1222 COVID-19 vaccine and low Incidence of SARS-CoV-2 infection in Botswana following ChAdOx1(AZD1222) vaccination: A single-arm open-label interventional study - final study results
Joseph Makhema, Emily Shava, Alane Izu, et al.
The Journal of Cell Biology
|
July 8, 2015
Schwann cell autophagy, myelinophagy, initiates myelin clearance from injured nerves
Jose A Gomez-Sanchez, Lucy Carty, Marta Iruarrizaga-Lejarreta, et al.
The Journal of Infection
|
March 2, 2024
AZD1222 effectiveness against severe COVID-19 in individuals with comorbidity or frailty: The RAVEN cohort study
Wilhelmine Meeraus, Mark Joy, Mario Ouwens, et al.
Page
of 2